IPSS-M should be derived from the validated molecular model.
This module standardizes downstream category interpretation and action framing.
Section 3
Pearls/Pitfalls
Result Bands
Very Low / Low
Lower-risk disease
Moderate-Low / Moderate-High
Intermediate biologic risk
High / Very High
Higher-risk disease often prompting disease-modifying strategy review
Section 4
Next Steps
Suggested Next Steps
01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5
Evidence Appraisal
Evidence Base
Interpreter for the official IPSS-M category after molecular MDS modeling.
OpiCalc Medical Oncology Module • Haematological Malignancies. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.
Section 6
Literature
Context
IPSS-M (Molecular MDS) is included in the oncology module as a structured decision-support tool for haematological malignancies workflows.
